Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-05-31$2.87/sh+844$2,422→ 1,386,215 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (2)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]These shares are directly owned by Mr. Golestaneh in his personal capacity.